Govt Job: For D.Pharm , B.Pharm under Medical Education | Pay Rs 60,500 per month

The Directorate of Medical Education, Assam, Training and Research, Assam was established in the year 1984 under the control of Health & Family Welfare Department, Government of Assam.

Post: Pharmacist

Online applications are invited from the citizens of India as defined under Article 5 and 6 of the Constitution of India for filling up of vacancies of different Grade-Ill posts (technical & non-technical) in existing vacant posts and newly create the Directorate of Medical Education. Assam and different Medical Colleges and Hospitals as well as Dental Nursing Colleges, Paramedical Institutes etc. of the Sate under the establishment of the Directorate of Medical E Assam

Pharmacist
No of Posts :
 06 [UR-4, ST(p)-01, OBC/MOBC-01]

Requisite qualification : HSSLC (Sc) or equivalent with Diploma in Pharmacy from Govt, recognized Institute

Pay Scale : Rs. 14,000-Rs. 60,500
Grade Pay : Rs. 7400/-

Chemist
No of Posts :
 01 [UR-01]

Requisite qualification : B.Sc with Chemistry/B.Pharm from a recognized Institute
Pay Scale : Rs. 14,000-Rs. 60,500
Grade Pay : Rs. 8700/-

Application Fee :No fee is required to be paid.

Selection Process :
Selection process shall be notified in the official website of the Directorate of Medical Education. Assam (dme.assam.gov.in) in due course of time.

The online application form shall also be uploaded in the same portal shortly. The candidates are requested to keep a watch in the portal.

Terms & Conditions :
Intending candidates are to check the official website of the Directorate of Medical Education, Assam (dme.assam.gov.in) I for detail terms & conditions and other criteria’s of the recruitment process which will be published in due course of time.

Last Date :18th February, 2022

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch